PLEKHA4 and melanoma: One study about Melanoma found that, PLEKHA4 was required for melanoma proliferation and survival, PLEKHA4 knockdown could attenuate tumor growth and enhance the effect of clinically used inhibitor encorafenib (Shami Shah et al., 2021).